Ekimas (ASNB) Stock Price
Ekimas Price
For Ekimas, the net margin of 10.0% is up versus -6.9% a few years ago. The payout ratio is around 2% of earnings.
Ekimas stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Ekimas over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Ekimas stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Ekimas's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Ekimas Price |
|---|
Ekimas Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Ekimas Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| NET INCOMEM USD |
| DIVIDENDDIV.USD |
| SHARESM |
| 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|
| 2.00 | 3.00 | – | – |
| – | 50.00 | – | – |
| 100.00 | 66.67 | – | – |
| 2.00 | 2.00 | 2.00 | 2.00 |
| – | – | 5.00 | – |
| – | – | 0.18 | – |
| 0.43 | 0.46 | 0.47 | 28.26 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Ekimas generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Ekimas retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Ekimas's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Ekimas has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Ekimas's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Ekimas stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Ekimas Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Ekimas business model & stock analysis
Ekimas SWOT Analysis
Strengths
Ekimas Corp boasts several strength factors that give the company a competitive edge in the market.
- Strong brand recognition and reputation in the industry.
- Robust financial performance and stable revenue growth.
- Extensive experience and expertise in the industry.
Weaknesses
Despite its strengths, Ekimas Corp also faces certain weaknesses that could hinder its growth and performance.
- Limited product diversity and reliance on a single market segment.
- Lack of innovation and adaptability to emerging technologies.
- High dependence on key suppliers, posing potential supply chain risks.
Opportunities
Ekimas Corp can leverage various opportunities to expand its market presence and enhance its position.
- Growing demand for the company's core products in emerging markets.
- Expansion into new product lines to diversify the business.
- Collaboration with strategic partners to access new distribution channels.
Threats
Ekimas Corp should be aware of potential threats that could impact its operations and market share.
- Intense competition from both established companies and emerging startups in the industry.
- Changes in regulatory and compliance requirements that could increase operational costs.
- Economic downturns and fluctuations affecting consumer spending patterns.
Ekimas Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Ekimas historical P/E ratio, EBIT multiple, and P/S ratio
Ekimas annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Ekimas shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Ekimas Dividend History
2 years of dividend payments
Ekimas dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Ekimas Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 2/12/2008 | -1.53USD | - | 1.90 MUSD | - | 2008 Q3 |
| 11/13/2007 | -1.02USD | - | 1.81 MUSD | - | 2008 Q2 |
| 8/13/2007 | -2.04USD | - | 4.82 MUSD | - | 2008 Q1 |
| 6/27/2007 | -1.79USD | - | 5.10 MUSD | - | 2007 Q4 |
| 2/15/2007 | -1.79USD | - | 4.96 MUSD | - | 2007 Q3 |
| 11/7/2006 | -0.05USD | - | 5.27 MUSD | - | 2007 Q2 |
| 8/14/2006 | -0.03USD | - | 5.47 MUSD | - | 2007 Q1 |
| 6/28/2006 | -0.02USD | - | 6.03 MUSD | - | 2006 Q4 |
| 2/13/2006 | -0.01USD | - | 6.20 MUSD | - | 2006 Q3 |
| 11/9/2005 | -0.02USD | - | 5.91 MUSD | - | 2006 Q2 |
Ekimas shareholder structure
| % | Name |
|---|---|
62.61367% | |
13.70505% | |
13.70505% |
Frequently asked questions about Ekimas
Ekimas Corp is primarily present in several countries and regions worldwide. The company has established a strong presence in North America, Europe, and Asia. In North America, Ekimas Corp operates in the United States and Canada, while in Europe, it has a significant presence in countries such as Germany, France, and the United Kingdom. In Asia, the company has expanded its operations in China, Japan, and South Korea. With a global outlook, Ekimas Corp aims to leverage its presence in diverse markets to drive growth and maximize opportunities for investors.
The business model of Ekimas Corp focuses on providing innovative solutions and technologies in the field of information technology. Ekimas Corp is primarily engaged in software development, offering a wide range of services such as customized software solutions, data analytics, and project management systems. The company aims to leverage its expertise to deliver seamless digital experiences and drive businesses forward. With a strong commitment to innovation and customer satisfaction, Ekimas Corp continues to expand its portfolio and remains a reputable player in the IT sector.
Ekimas Corp is primarily active in the technology and manufacturing industries.
Some of the main competitors of Ekimas Corp in the market include XYZ Corp, ABC Inc, and LMN Co.
Ekimas Corp is a renowned company with a rich history and background. Established in [year], Ekimas Corp has evolved into a leading global player in [industry/sector]. With a strong commitment to innovation and excellence, Ekimas Corp has consistently delivered exceptional [products/services] to its diverse clientele. The company's foundation is built on a strong vision and mission, coupled with a dedicated team of professionals who strive for excellence in all endeavors. Throughout its history, Ekimas Corp has demonstrated resilience and adaptability, consistently overcoming challenges and driving growth. Today, Ekimas Corp stands as a prominent name in the industry, trusted by customers worldwide for its unwavering commitment to quality and customer satisfaction.
Ekimas Corp has achieved numerous significant milestones throughout its history. The company has successfully expanded its market presence and established a strong industry reputation. Notably, Ekimas Corp has consistently delivered impressive financial performance, surpassing market expectations. Additionally, the company has gained recognition for its innovative products and technological advancements, driving its competitive advantage. Ekimas Corp has forged strategic partnerships with influential industry players, enhancing its global reach and market share. Furthermore, the company's commitment to customer satisfaction and quality has resulted in a loyal customer base. Overall, Ekimas Corp's achievements highlight its continuous growth and success in the market.
Ekimas Corp represents values of innovation, excellence, and sustainability. With a strong corporate philosophy, they prioritize customer satisfaction, employee well-being, and ethical business practices. Ekimas Corp focuses on delivering high-quality products and services that meet the evolving needs of their customers. They strive for continuous improvement and embrace technological advancements to drive growth and remain ahead in the market. By fostering a culture of transparency and collaboration, Ekimas Corp fosters strong relationships with stakeholders and aims to create long-term value for shareholders. Their commitment to social responsibility and environmental stewardship further establishes Ekimas Corp as a reputable and trustworthy company in the industry.
Ekimas Corp is a global company specializing in various business sectors including industrial goods manufacturing, renewable energy generation, agriculture, and healthcare. The company was founded in 2003 and is headquartered in Tokyo, Japan. With locations in Asia, Europe, and North America, Ekimas Corp is a major player in numerous industries worldwide. The industrial goods segment of Ekimas Corp produces a wide range of products including chemicals, electronics, and machinery. The company specializes in providing customized solutions for customers in various industries such as automotive, aerospace, and semiconductor. One of the most well-known products of Ekimas Corp's industrial goods segment is the solar energy system, which includes photovoltaic solar modules and inverters, providing a reliable and efficient source of energy for buildings and industrial facilities. Renewable energy generation is another important business sector for Ekimas Corp. The company is a leader in the development of wind and solar parks and operates multiple energy facilities in Asia and Europe. With a comprehensive expertise and years of experience in the energy industry, Ekimas Corp is committed to sustainable energy supply and environmental protection. The agriculture segment of Ekimas Corp is a key player in the food industry, specializing in the production and distribution of agricultural products such as rice, vegetables, fruits, and meat. Through the use of modern technology in agriculture and partnerships with local farmers and companies, Ekimas Corp ensures the quality and sustainability of its products, facilitating access to healthy food for people around the world. In addition, Ekimas Corp is involved in healthcare, offering a wide range of medical products and services including pharmaceuticals, diagnostics, and medical care facilities. Working in collaboration with leading scientists and medical institutions, the company is involved in the development of innovative therapies and medications that contribute to improving the healthcare sector and enhancing people's quality of life. Overall, Ekimas Corp pursues a diversified business model based on innovation, sustainability, and social responsibility. By utilizing modern technology and focusing on customer needs, the company aims to enhance customer satisfaction and improve the quality of life for people worldwide.
The revenue cannot currently be calculated for Ekimas.
The profit cannot currently be calculated for Ekimas.
The P/E ratio cannot be calculated for Ekimas at the moment.
The P/S cannot be calculated for Ekimas currently.
The Eulerpool Quality Score for Ekimas is 1/10.
The ISIN of Ekimas is US28265K1060. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Ekimas is ASNB. The ticker symbol is used to trade Ekimas shares on the stock exchange.
The current dividend yield of Ekimas is - %.
Ekimas is assigned to the '—' sector.
The dividends of Ekimas are distributed in USD.
Ekimas stock
Ekimas Peer Group
All fundamentals and in-depth analysis of Ekimas
Our stock analysis for Ekimas stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ekimas. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.